Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CACNA1G | O43497 | 9/20 | 0.39 |
| ▸ | CACNA1H | O95180 | 9/20 | 0.39 |
| ▸ | CACNA1I | Q9P0X4 | 9/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.36 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2811925 | 0.86 | CACNA1G (0.42) | ALDH1A1HPGDCACNA1GCACNA1HCACNA1I | |
| SCHEMBL538332 | 0.85 | CACNA1G (0.39) | HPGDCACNA1GCACNA1HCACNA1INPSR1 | |
| SCHEMBL2815942 | 0.84 | MC4R (0.43) | ALDH1A1HPGDCACNA1GCACNA1HCACNA1I | |
| SCHEMBL2812033 | 0.83 | P2RX7 (0.42) | CACNA1GCACNA1HCACNA1I | |
| SCHEMBL2812129 | 0.83 | P2RX7 (0.44) | CACNA1GCACNA1HCACNA1I | |
| SCHEMBL538580 | 0.82 | CACNA1G (0.41) | ALDH1A1CACNA1GCACNA1HCACNA1IEPHX2 | |
| SCHEMBL2814282 | 0.82 | KMT2A (0.42) | ALDH1A1CACNA1GCACNA1HCACNA1IEPHX2 | |
| SCHEMBL2812141 | 0.82 | ALDH1A1 (0.43) | USP2ALDH1A1CACNA1GCACNA1HCACNA1I | |
| SCHEMBL2812069 | 0.81 | BRS3 (0.41) | ALDH1A1CACNA1GCACNA1HCACNA1IEPHX2 | |
| SCHEMBL538550 | 0.81 | CACNA1I (0.44) | ALDH1A1CACNA1GCACNA1HCACNA1I |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8343983-B2 | Substituted pyrazolo-pyrimidine compounds | ARQULE, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8343983-B2 | Substituted pyrazolo-pyrimidine compounds | ARQULE, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-8343983-B2 | Substituted pyrazolo-pyrimidine compounds | ARQULE, INC. (US) | 2013-01-01 | — | — | US | disclosed |
| US-20100249110-A1 | SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS | ARQULE, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100249110-A1 | SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS | ARQULE, INC. (US) | 2010-09-30 | — | — | US | disclosed |
| US-20100249110-A1 | SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS | ARQULE, INC. (US) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249110-A1 | SUBSTITUTED PYRAZOLO-PYRIMIDINE COMPOUNDS | DPYD, TYMP, TP53 | USP2 4725/4885ALDH1A1 924/4885HPGD 193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.